|
|
 |
|
Viewing report
|
|
|
|
Tamir Biotechnology, Inc. - Product Pipeline Review - H2 2011
Global Markets Direct, Dec 2011, Pages: 53
Tamir Biotechnology, Inc. – Product Pipeline Review – H2 2011
Summary
Global Market Direct’s pharmaceuticals report, “Tamir Biotechnology, Inc. - Product Pipeline Review - H2 2011” provides data on the Tamir Biotechnology, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Tamir Biotechnology, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Tamir Biotechnology, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Tamir Biotechnology, Inc. - Brief Tamir Biotechnology, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Tamir Biotechnology, Inc. human therapeutic division.
- Ov
|
|
|
|
